Orexo AB

Orexo AB
Stock Exchange OTC Publication Venue
EPS
SEK5.09
Market Cap
SEK2.44 B
Shares Outstanding
34.67 M
Public Float
18.52 M

Profile

Address
Rapsgatan 7e
Uppsala UP 751 05
Sweden
Employees -
Website http://www.orexo.com
Updated 07/08/2019
Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. Its focuses on the treatment of opioid dependence. Its pipeline comprises of Zubsolv, Abstral, Edluar, Zubsolv, OX51, OX-MP1, and OX382.

Financials

View All

Henrik Kjaer Hansen
Director
Alf Gunnar Martin Nicklasson
Chairman